Building a better world
Europe’s most successful science park
A vibrant community of like-minded people
Combining science and nature
Visiting the park
Next bus departing
Visiting a company?
Plan your bus journey
Next train departing
21:27 - London Kings Cross
Leaving Cambridge
21:30 - Stansted Airport
Leaving Cambridge
21:31 - London Kings Cross
Leaving Cambridge North
21:22 - Cambridge North
Leaving Cambridge
About the Cambridge Science Park
The Cambridge Science Park was established 48 years ago when Trinity College Cambridge embraced the concept that would change the hi-tech sector in Cambridge, the UK and beyond. Trinity owns the freehold of the Cambridge Science Park, which today comprises 150 acres, 1.7 million sq ft of high technology and laboratory buildings. It’s home to 7500 people at over 100 companies, ranging from exciting start-ups to some of the world's leading technology businesses.
Over 100 entrepreneurial businesses
Companies and entrepreneurs at the Cambridge Science Park are working on life-enhancing technologies, ranging from non-invasive diagnostics and novel medicines to next-generation display and communications technologies, to name just a few. The wide range of occupiers in terms of size, sector, age and nationality offers unrivalled opportunities for collaboration, innovation and inspiration.
-
Twist DX
Life Sciences
-
Roku Europe Ltd
Technology
-
Ricardo UK Ltd
Technology
-
CS Genetics
Life Sciences
-
Citrix Systems UK Ltd
Technology
-
Mind The Product Ltd
Technology
-
GEMA Digital UK Ltd
Technology
-
Trial by Fun
Technology
-
AVEVA (Schneider Electric)
Technology
-
Auriplex
Life Sciences
-
AstraZeneca
Life Sciences
-
NextMove Software
Life Sciences
The latest news, discoveries and innovations
See all newsTWEET by @Amgen
#Amgen partners with leading healthcare authorities to take cholesterol management awareness to new heights by lighting up Dubai’s Burj Khalifa with video about importance of managing cholesterol levels. Watch here: bit.ly/2GhHvWg #emergencycholesterol #AmgenCV #WCCDubai
TWEET by @Amgen
Breaking News: @US_FDA approves Nplate® (romiplostim) for use in pediatric patients. Learn more: bit.ly/2rzXrcd
Contact us
Thank you for your enquiry!
We'll be in touch soon.